2008
DOI: 10.1089/gte.2008.0035
|View full text |Cite
|
Sign up to set email alerts
|

Development and Pilot Testing of a Decision Aid for Men Considering Genetic Testing for Breast and/or Ovarian Cancer–Related Mutations (BRCA1/2)

Abstract: Despite the fact that both men and women can carry a breast/ovarian cancer-related mutation, the main emphasis in genetic counseling for breast/ovarian cancer-related risk remains on females. This study aimed to develop and pilot a decision aid specifically designed for men with a strong family history of breast and/or ovarian cancer who are considering genetic testing. The decision aid was developed by a multidisciplinary team of experts and a consumer representative. It was then reviewed by 27 men who had pr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2009
2009
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 43 publications
0
5
0
Order By: Relevance
“…Future research about male carriers of BRCA mutations should explore this possibility. A decision‐aid specifically designed for men considering genetic testing for breast cancer mutations is an example of useful interventions that healthcare professionals should be aware of.…”
Section: Discussionmentioning
confidence: 99%
“…Future research about male carriers of BRCA mutations should explore this possibility. A decision‐aid specifically designed for men considering genetic testing for breast cancer mutations is an example of useful interventions that healthcare professionals should be aware of.…”
Section: Discussionmentioning
confidence: 99%
“…Despite the perception that BRCA1/2 genetic testing is relevant primarily for women, both men and women are equally likely to inherit a mutation [1, 2]. Women who inherit a BRCA1 or BRCA2 mutation face significantly elevated lifetime risks of breast and ovarian cancer (up to 65 and 40%, respectively), for which aggressive surveillance and surgical risk reduction options are recommended [3–5].…”
Section: Introductionmentioning
confidence: 99%
“…2. Resource acceptability: Six questions were based on the validated O'Connor and Cranney (1996) User Manual Acceptability, which has been successfully used in prior resource evaluations (Juan et al, 2008).…”
Section: Methodsmentioning
confidence: 99%
“…Resource acceptability : Six questions were based on the validated O’Connor and Cranney (1996) User Manual Acceptability , which has been successfully used in prior resource evaluations (Juan et al, 2008). Grandparents were asked to rate each section of the booklet on a 4-point scale (1 = poor to 4 = excellent ).…”
Section: Methodsmentioning
confidence: 99%